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Introduktion 
 
1.1.1 Embryology and anatomy of the heart   
              
The cardiovascular system is the first functional organ system of an 
embryo. The embryonic development of the heart is a complicated process 
and it lasts several weeks (27). The heart develops in a modular 
sequence. Primary cardiac crescent (PCC) forms within the splanchnic 
layer of the cranial lateral plate mesoderm. Within the embryonic folding, 
the most cranial portion of PCC comes to lie ventral to foregut endoderm. 
The primitive heart tube is the result of the fusion of limbs of PCC as lateral 
body folds move medially. The left ventricle develops from the primary 
cardiac crescent, the right ventricle and outflow tract originate from the 
secondary heart field, and cells that form the atria, contribute to the 
formation of ventricles. The left and right patterning within the heart is 
established early in the gastrulation. The ballooning model tries to explain 
the development of the atrial and ventricular chambers; atrial chambers 
balloon from primitive atrium, atrial septum grows between systemic und 
pulmonary veins as well as atrial appendages balloon from the initial 
common atrium. Ventricles balloon from the initially common ventricle. 
 The contruncus constitutes the outflow tract of the primitive heart tube; 
the conus arteriosus constitutes the right and the left ventricular outflow 
tracts. The truncus arteriosus constitutes the ascending aorta and 
pulmonary trunk. Paired dorsal aortae develop into mesenchym on either 
side of the notochord, the heart tube is rotated into chest as cranial end of 
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embryo bends, the dorsal aortae follow in a loop, which is the aortic arch 
and the paired dorsal aortae fuse from the 4th thoracic to the 4th lumbar 
vertebrae and to a single midline aorta. 
 In the fetus main pulmonary artery (PA) trifucates into ductus arteriosus 
(DA), right pulmonary artery (RPA) and left pulmonary artery (LPA). 
Vitelline veins carry blood from the yolk sac to the embryo and give rise to 
the venous plexus within the developing liver, and they are precursor to 
sinusoids and hepatic/portal veins. Hepatic sinusoids interrupt cranial 
portions of UV and VV between the developing liver and heart. Cardinal 
veins drain the embryonic disc. The sinus venosus of the primitive heart 
tube is a pair of common cardinals veins via two sinus horns; the right 
sinus horn eventually drains all systemic venous returns by developing 
superior/ inferior vena cavae, and it incorporates into the wall of the right 
atrium. 
 The umbilical veins drain the chorion; the remaining left umbilical vein 
becomes the conduit for oxygenated blood returning from the placenta to 
the embryo. Ductus venosus drived from left umbilical vein acts as a liver 
bypass to carry umbilical vein blood primarily to the inferior vena cava 
(IVC) and the heart (21,31). 
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1.1.2. Fetal circulation 
 
 Blood is oxygenated by the placenta in the fetus and returns to the heart 
via the umbilical vein. This enters the liver to anastomose with the left 
portal vein. From here, the oxygenated bood is directed across the 
foramen ovale to the left side of the heart. Deoxygenated blood returns to 
the right atrium via the superior and inferior vena cavae. This blood flows 
into the right ventricle and pulmonary artery. Most of the right ventricular 
output enters the ductus arteriosus to join the descending aorta, which 
perfuses most of the fetal torso. 
 
 
1.1.3.   Fallot-tetralogy 
 
 The tetralogy of Fallot (TOF) is a congenital heart disease and it is defined 
by an obstruction of the right ventricular outflow tract (RVOT), a ventricular 
septal defect (VSD), an overriding aorta and a right ventricular 
hypertrophy. TOF ist the most common cyanotic congenital heart disease. 
5% of all liveborn with cyanotic heart disease have TOF. The embryonic 
mechanism remains uncertain due to its complexity (34). It is supposed to 
be an incomplete rotation of the conotruncus and a deviation of the conal 
septum anterior, superior and leftwards.  
Concerning the etiology of TOF, diabetic mothers present a high risk  
(RR 3:1). Mothers with phenylketonuria that use retinoic acids and 
trimethadione show an increased risk as well. TOF may occur in the 
CHARGE Syndrom, VACTERL association, 22q11.2 deletion and trisomy 
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21. ToF ist classified in three groups; The first category of ´´TOF with 
pulmonary stenosis´´ can be subdivided into two subgroups based on the 
degree of stenosis, i.e. mild or no stenosis and moderate to severe 
stenosis. The other categories are ``TOF with the pulmonary atresie`` and 
``TOF with absent pulmonary valve``. 
 The VSD and the overriding aorta are the standard echocardiographic 
findings. The pulmonary stenosis is the result of the minderperfusion of 
the valve with a consequent hypertrophy of the right ventricle. The 4-
chamber view (4CV) is normal in > 95% of prenatal cases. Concerning the 
treatment, the prenatal consultation with neonatology and pediatric 
cardiology is necessary and the delivery plan should be scheduled at a 
tertiary center. Follow-up for progressive RVOT obstruction is essential, 
because an early intervention may be required in case of significant RVOT 
obstruction. The surgical repair includes the VSD closure and the right 
ventricular outflow tract reconstruction with valve-sparing, infundibular 
ressection, transannular patch and RV-pulmonary artery conduit (6). The 
prognosis will be determined by the aneuploid syndrom; if isolated, it has 
an excellent short -and long- term outcome with definitive repair. 
 
 
1.1.4 Absent pulmonary valve syndrome 
 
 With the absent pulmonary valve syndrome (APVS), the pulmonary valve 
leaflets are absent or severely undeveloped with a restrictive ring of 
thickened tissue in the position of the pulmonary valve annulus. This may 
lead to a marked pulmonary insufficiency with a to- and from- blood flow 
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over the dysplastic valve, an aneurysmal dilation of the main and branch 
pulmonary arteries and concomitant cardiomegaly, causing compression 
of the bronchi. Absence of the ductus arteriosus is common with APVS 
and it has been postulated that absence of the arterial duct plays an 
important etiologic role in APVS.  
 APVS carries a significant perinatal mortality und morbidity and a 
postnatal presentation may be aggrevated by severe respiratory 
symptoms including long-term obstructive lung disease. 
Absent pulmonary valve syndrome (APVS) occurs with the tetralogy of 
Fallot (TOF/APVS) and with an intact ventricular septum (APVS/IVS) in 
the setting of isolated APVS or associated with tricuspid atresia, Ebstein 
anomaly or in combination with an absent aortic valve. In the majority of 
cases, the ductus arteriosus is absent. Connection of a discontinuous left 
pulmonary artery to the patent arterial duct has been described for a few 
rare cases (12,31). 
In postnatal series, it accounts for 2-6 % of all cases with TOF and 0.2-
0.6% of all congenital heart defects. In prenatal series, it accounts for 
approximately 20% of all cases with TOF and 1% of all congenital heart 
defects (4,13,16). Intrauterine demise due to cardiac failure, hydrops 
fetalis, extracardiac and chromosomal associations as well as termination 
of pregnacy (TOP) might acount for different incidents in pre- and postnatal 
series and the potentially better outcome in recent postnatal series with 
reported survival rates of 72%-86%.  
 Most studies deal with cases diagnosed from the second trimester and 
few cases have been described within the first trimester (3,4). 
In Figure 1,2,3,4 and 5 are shown the most common sonographic findings. 
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Figure 1 
 
 
Figure 1 Fetus with TOF/APVS and dilated RPA and LPA. 
(TOF, Tetralogy of Fallot; APVS, absent pulmonary valve 
syndrome; RPA, right pulmonary artery; LPA, left pulmo-
nary artery; RA, right atrium; IVC, inferior vena cava; Ao Asc, 
ascending aorta; *, pulmonary fibrous annulus) 
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Figure 2 
 
 
 
 
Figure 2 Fetus (21 weeks of gestation) with APVS, ventricular sep-
tum defect and right aortic arch. On short-axis view at the 
level of the great vessels systolic antegrade flow (blue) and 
diastolic retrograde flow (red) across pulmonary fibrous 
annulus are visualized.  
 (APVS, absent pulmonary valve syndrome; RV, right ventri-
cle; Ao, aorta; MPA, main pulmonary artery) 
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Figure 3 
 
 
 
 
Figure 3 Fetus of 31 weeks of gestation with APVS/IVS. Ductal arch 
view with color Doppler demonstrates:  
A) patent DA with blood flow (big arrow) and dilated LPA 
and RPA 
B) severe pulmonary regurgitation (arrow) across pulmo-
nary fibrous annulus  
 (APVS, absent pulmonary valve syndrome; IVS, intact ven-
tricular septum; DA, ductus arteriosus; MPA, main pulmo-
nary artery; LPA, left pulmonary artery; RPA, right pulmo-
nary artery; Ao, aorta; RV, right ventricle; Ao Desc, descend-
ing aorta. 
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Figure 4 
 
 
 
 
 
Figure 4 The same fetus of 31 weeks of gestation with APVS/IVS. On 
long-axis view of the LVOT, IVS (arrow) without any inter-
ventricular shunt on color Doppler is visualized.  
(APVS, absent pulmonary valve syndrome; IVS, intact ven-
tricular septum; LVOT, left ventricular outflow tract; LV, left 
ventricle; RV, right ventricle; Ao, aorta) 
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Figure 5 
 
 
 
Figure 5 Fetus of 21 weeks of gestation with APVS, ventricular sep-
tum defect and right aortic arch.    
A) On three vessels view dilated pulmonary arteries (ar-
rows) are shown;  
B) B) Short-axis view at the level of the great vessels visual-
izes dilated main pulmonary artery (MPA), left (LPA) and 
right (RPA) pulmonary branches and severe pulmonary 
regurgitation (arrow) across narrow pulmonary fibrous 
annulus.  
(APVS, absent pulmonary valve syndrome; Ao Asc, ascend-
ing aorta; Ao Desc, descending aorta) 
 
 
 
1.1.5. 22q11.2 Deletion Syndrome 
 
 The 22q11.2 Deletion Syndrome is one of the most recognizable 
chromosome abnormalities causing heart defects (15). It is characterised 
by conotruncal heart defects, such as a right-sided aortic arch or an 
interrupted aortic arch, as well as tetralogy of Fallot, cleft palate, 
micrognathia and hypertelorism. It is an autosomal dominant disease, 
caused by a haploinsufficiency of 3 genes in del22q11.2. 
 22q11.2 deletion syndrome or DiGeorge syndrome cannot be diagnosed 
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by routine karyotype, but requires fluorescence in situ hybridization. It is a 
rare anomaly (1:3000 live births). Concerning the postnatal signs and 
symptoms, the phenotype is often quite subtle. The congenital heart 
disease ist the most common sign (74%). The palatal abnormalities such 
as velopharyngeal insufficiency, submucosal cleft palate and cleft palate 
are the second most common sign with 69%. Other characterisitc facial 
features are the prominent broad nasal bridge, the widely spaced eyes, 
the downturned mouth, the small recessed jaw and the bulbous nasal tip. 
These children show learning disabilites, feeding problems, hypocalcemia, 
hearing loss and suffer from immune deficiency through a thymic 
hypo/aplasie. In all cases a genetic counselling is required. A prenatal 
diagnosis by FISH-analysis of amniocytes is unavoidable in high-risk 
pregnacies based on sonographic findings such as conotruncal heart 
defect and or cleft palate.  Delivery should take place in a tertiary center 
(31). 
 
2. Goals 
 
 Absent pulmonary valve syndrome (APVS) is a rare congenital heart 
anomaly and is frequently associated with tetralogy of Fallot. Risk faktors 
for poor outcome include karyotype abnormalities, presence of hydrops 
fetalis and respiratory failure in live born patients.  
The goal of this study is to analyze the spectrum of prenatally diagnosed 
absent pulmonary valve syndrome (APVS) and the outcome from 
diagnosis onwards of fetuses with APVS and tetralogy of Fallot 
(TOF/APVS) and with APVS and intact ventricular septum(APVS/IVS). 
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The current study ist the largest study to date analyzing fetal outcome.  
 
 
 
 
3. Methods 
 
 This was a multicenter retrospective analysis of all subjects with a 
diagnosis of APVS 2012 to 2016. Data from 9 european referral centers 
from the International Prenatal Cardiology Collaboration Group (IPCCG) 
were included. The anatomic survey and fetal echocardiography were 
performed in a standardized fashion according to international guidelines 
of ISUOG by a segmental approach and defined anatomical planes with 
colour Doppler and pulsed-wave interrogation (32,6). Cardiovascular 
analysis was performed by two dimensional, colour and pulsed- wave 
Doppler echocardiography and was followed by postnatal 
echocardiography, surgery and /or autopsy. Spectral Doppler interrogation 
of the umbilical artery, middle cerebral artery and the ductus venosus was 
performed in a standardized manor. 5MHz, 7.5MHz or 9 MHz sector or 
curved array-probes were used for all ultrasound examinations (Toshiba 
Aplio 500, Toshiba Aplio XG, Toshiba Medical, Neuss, Germany, Philips 
IU22, Philips Epiq7, Hamburg, Germany, Voluson 730 Expert, Voluson E8, 
GE Heathcare Solingen, Germany; Acuson Sequoia 512, Siemens, 
Germany). In the first trimester transvaginal sonography was part of the 
study whenever appropriate. Fetal karyotyping was offered and included 
chromosome analysis and fluorescent in-situ hybridization for 
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microdeletion 22q11.2. Parental counselling by pediatric cardiologists and 
geneticists was part of the prenatal work-up. Data were collected from 
medical files, from stored ultrasound images and video loops, whenever 
available. Echocardiographic parameters included presence or absence 
of arterial duct (DA), aortic arch position and the cardiothoracic ratio 
(CTR), maximum diameters of pulmonary annulus and the diameter of the 
right or left branch pulmonary artery either prospectively or retrospectively. 
Z-scores of PV annulus, branch pulmonary arteries and DA were 
generated by the use of previously published normative data for fetal 
pulmonary artery diameters (22). Clinical variables included indication for 
referral, gestational age at diagnosis, gestational age at birth, maternal 
age, associated extracardiac anomalies including karyotype 
abnormalities, presence of hydrops fetalis, the notification of an increased 
nuchal tranlucency (NT) within the first trimester, and pregnacy outcome.     
For subjects born alive, postnatal diagnosis and survival beyond the 
neonatal period was documented. Statistical analysis was performed 
using X2, student t-test or Fischer’s exact test.  
All values are given in mean +/- standard deviation (SD) unless otherwise 
stated. A p –value<0.05 was considered significant. Institutional review 
board approval of the main side (Justus-Liebig-University, Giessen, 
Germany) was obtained. 
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4. Results 
 
 During the study period 71 cases with APVS were diagnosed antenatally. 
59 fetuses (83.1%) were classified as having TOF/APVS, 12 (16.9%) of 
the cases presented with APVS/IVS as shown in figures 1-5. One case of 
the latter group additionally had a membranous tricuspid atresia and a 
non-compaction of the right ventricle. In all cases confirmation of the 
prenatal diagnosis by necropsy or postnatal echocardiography/surgery 
was obtained neither encoutering false positive nor incorrect diagnoses. 
  Table 1 details general information on the total study cohort. Nine cases 
of the total cohort were lost to follow up. Mean gestational age at diagnosis 
was 21.5 weeks of gestation (wks) for the whole cohort, without significant 
differences among fetuses presenting TOF/APVS (22.3 wks) and 
APVS/IVS (20.2 wks). Hydops fetalis was found in eleven cases (16.9%). 
Seven cases with TOF/APVS presented with hydrops (13.2%), in contrast 
to four cases with APVS/IVS (33.3%, p<0.04). A patent DA was found in 
five fetuses with hydrops fetalis (31.3%). Among those five fetuses two 
had TOF/APVS and three had APVS/IVS. Patency of DA was registered 
in 14 of 53 cases (26.4%) without hydrops. Information on intrauterine fetal 
demise (IUD) was obtained in sixty two cases (85.9%). IUD occured nine 
times (14.7%) in the total cohort. IUD was registered in six of fifty three 
cases with TOF/APVS (11.3%) in contrast to three of nine (33.3%) in 
APVS/IVS. In four of those nine cases DA was patent (44.4%). Information 
on both IUD and presence/absence of DA was obtained in fifty cases 
(70.4%).  Six IUDs patency of the DA was observed in four cases (66.6%). 
Of the latter four fetuses two presented with TOF/APVS and APVS/IV 
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each. 
 In twenty three of sixty two cases with ascertained information parents 
opted for TOP (37.7 %). TOP was performed in twenty one cases with 
TOF/APVS (39.6%) and two cases with APVS /IVS (22.2%). Among TOPs 
there were seven cases presenting aneuploidy, four cases (17.4%) with 
hydrops fetalis and ten cases with extracardiac anomalies (43.5%). 
Consequently survival to birth was twenty six of fifty three cases (49.1%) 
within the TOF/APVS group, and three of eight in the APVS/IVS cohort 
(35%, one ongoing pregnacy). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 20 
 
Table 1 
Parameter TOF/APVS 
 
APVS/IVS 
 
level of 
significanc
e (p-value) 
Number of fetuses (n) 59 12  
Lost for follow up 6 3  
Mean GA (weeks) 22 21 0.48 
Hydrops (n) 7/53 (13.2%) 4/9 (44.4%) 0.04* 
IUD (n) 6/53 (11.3%) 3/9 (33.3%) 0.08 
TOP (n) 21/53 
(39.6%) 
2/9 (22.2%) 0.32 
Live birth (n) 26/53 
(49.1%) 
3/8 (37.5%) 0.54 
Postnatal survival >28 days (n) 18/49 
(36.7%) 
3/8 (37.5%) 0.97 
Table 1 General information of study population according to type of 
APVS and additional level of significance, expressed by p-values. 
(GA, gestational age; IUD, intrauterine demise; TOP, termination of 
pregnancy) 
 
 
  Four newborns of twenty nine live births (13.7%), all within the cohort of 
TOF/APVS, died within the neonatal period, and all showed severe 
respiratory failure. Further four were lost to follow up after live birth. 
Subsequently, survivals beyond the neonatal period in actively managed 
cases in TOF/APVS was eighteen of fourty five cases (40 %) compared to 
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three of eight with APVS/IVS (37.5 %). In total, survival from initial 
diagnosis beyond the neonatal period was eighteen of fifty three with 
TOF/APVS (33.9%) compared to three of eight (37.5%, one ongoing 
pregnacy) in APVS/ IVS (figure 6). 
 
 
Figure 6 
 
 
Figure 6  
            Flowchart of overall study population and outcome according to the type of  
            APVS. 
 (TOF, Tetralogy of Fallot; APVS, absent pulmonary valve syndrome; IVS, 
           intact    ventricular septum; IUD, intrauterine demise; TOP, termination of  
           pregnancy) 
 
 
 
 Extracardiac non –chromosomal anomalies were frequent in both cohorts 
occuring in thirty six of seventy-one fetuses (50.7%). Anomalies 
predominantly included the central nervous system, urogenital anomalies 
and gastointestinal anomalies. Agenesis of the thymus occured in five 
cases, four of them with TOF/APVS (table 2) 
cases included 
n=71 
TOF+APVS 
n=59 
IUD 
n=6 
TOP 
n=21 
lost follow up 
n=6 
live birth 
n=26 
postnatal survival 
n=18 
postnatal death 
n=4 
lost follow up 
n=4 
APVS/IVS 
n=12 
IUD 
n=3 
TOP 
n=2 
lost follow up 
n=3 
live birth 
n=3 
postnatal survival 
n=3 
ongoing pregnancy 
n=1 
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Table 2 
 TOF/APVS  
(n) 
APVS/IVS 
(n) 
Thymic agenesis 4 1 
SUA 2  
ARSA 1  
Holoprosencephaly 3  
Polyhydramnios 2 1 
Oligo-/Anhydramnios 2  
Renal agenesis 1  
Anencephaly 1  
Omphalocele 3 2 
Polydactyly 2 1 
Gastroschisis  1 
Enlarged Cisterna magna  1 
Cystic hygroma  1 
Cleft palate  1 
Agenesis of corpus callosum  1 
Agenesis of DV 1  
Placentomegaly 1 1 
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Hyperechogenic bowl 1  
Agenesis of cerebellar vermis 1  
 
Table 2 Extracardiac anomalies according to type of APVS. 
(TOF, Tetralogy of Fallot; APVS, absent pulmonary valve syndrome; IVS, intact 
ventricular septum; SUA, single umbilical artery; ARSA, absent right subclavian 
artery; DV, ductus venosus) 
 
Information on prenatal karyotype results were retrieved in twenty nine 
fetuses (40. 8%). Sixteen of tweenty- nine fetuses (55.1%) presented with 
a normal karyotype. There were five cases with trisomy 13 (17.2%) and 
two cases of trisomy 18 (6.8%) respectively. The two fetuses with trisomy 
18 occured in the APVS/IVS group, whereas all five trisomy thirteen cases 
occured within the group of TOF/APVS. All six fetuses with microdeletion 
22q11.2 (20.6%) occured within the TOF/APVS cohort (Table 3). 
 
Table 3 
 TOF/APVS APVS/IVS 
normal 11 5 
trisomy 18 0 2 
trisomy 13 5 0 
del22q11.2 6 0 
 
Table 3 Distribution of fetuses with known karyotyping according to type of  
                      APVS  
                      
 Table 4 summarizes information on echocardiographic details of the 
cohort. Assessment of cardiac axis was available in fourty nine (69%) 
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cases of the cohort. Counterclockwise leftward rotation of the cardiac axis 
was found in fourty four fetuses (89.8%), whereas a normal cardiac axis 
was seen in five fetuses (10.2%) all of them having TOF/APVS. All seven 
cases with APVS/IVS with known information on cardiac axis showed 
abnormal leftward rotation. The vast majority (88.1%) of TOF /APVS cases 
showed abnormal leftward rotation of the cardiac axis compared to only 
five fetuses (11.9%) with TOF/APVS having a normal cardiac axis. 
Laterality of the aortic arch (RAA) occured within the group of TOF/APVS 
(p=0.1, figure 5). Although no case of RAA was found in the group of 
APVS/IVS, the comparison between both groups was statistically not 
significant. In fifty of seventy one cases (70.4%) infomation on patency of 
the DA was retrieved. In thirty two fetuses (62.7%) the DA was absent, 
whereas in eighteen (37.3%) a DA was present. All cases with absent DA 
occured in the TOF/APVS group. In contrast to nine of fourty one 
TOF/APVS with patent DA was (21.9%) all nine cases with APVS/IVS had 
a patent DA (p<0.001). In one ongoing pregnacy with APVS/IVS and 
membranous TA (fig. 2) a narrow duct with z- scores ranging from –2.34 
at 23+4 wks to -3.09 at 25+6 wks was diagnosed.  
  All seven cases with RAA occurred in the TOF/APVS group (p00.1, figure 
5). The pulmonary artery valve to- aortic valve annular ratio was higher in 
APVS/IVS cases compared to TOF/APVS cases (p<0.02, figure 5). 
However, in TOF/APVS the pulmonary artery valve to- aortic valve annular 
ratio did not differ significantly in survivors from non-survivors (p<0.02, 
table 4). 
 
 
 25 
 
Table 4 
Parameter TOF/APVS APVS/IVS level of 
significanc
e (p-value) 
CTR 0.55 0.57 0.72 
Abnormal heart axis 37/42 
(88.1%) 
7/7 (100%) 0.34 
Patency of DA 9/41 (22.0%) 9/9 (100%) <0.001* 
RAA 7/24 (29.2%) 0/7 (0%) 0.1 
PV/AV ratio 0.92 1.42 0.02* 
Heart dimensions (Z-scores)    
MPA 3.7 (1.8 – 
9.1) 
  
RPA 5.9 (2.6 – 
9.2) 
  
LPA 5.7 (2.1 – 
7.7) 
  
 
 
Table 4 Fetal echocardiographic findings according to type of APVS 
and additional level of significance, expressed by p-values. 
(CTR, cardiothoracic circumference ratio; DA, ductus arteriosus; RAA, 
right aortic arch; PV, pulmonary valve; AV, aortic valve) 
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 Figure 7-9 display z- scores of main and branch pulmonary arteries at 
time of diagnosis and throughout gestation in TOF/APVS with ascertained 
information. In all cases with ascertained measurement after the first 
trimester persistently increased diameters in MPA and branch pulmonary 
arteries were measured from time of diagnosis onwards. In four cases with 
information on PA measurement in the first trimester, diameters were 
already markedly increased at this time in gestation, however a correlation 
of the presence of the DA with the size of the main and branch pulmonary 
arteries could not be established in those four cases.  
In one case with APVS/IVS with membranous tricuspid atresia and patent 
arterial duct, significant pulmonary regurgitation was present. However z-
scores of the arterial duct were –2.34 at 23.4 wks and -3.09 at 25+6 wks 
indicating a significant narrowing of the arterial duct. Of note the right and 
left PA branches and the MPA were of normal size (z-sores 1.15, 1.75 and 
0.61 respectively). 
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Figure 7 
 
 
 
Figure 7 Fetal Z-score values of main pulmonary arteries (MPA) at time of 
diagnosis and throughout gestation in 11 serially followed cases with TOF/APVS and 
one case with APVS/IVS. 
 (TOF, Tetralogy of Fallot; APVS, absent pulmonary valve syndrome; IVS, 
intact ventricular septum) 
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Figure 8 
 
 
 
Figure 8 Fetal Z-score values of right pulmonary arteries (RPA) at time of 
diagnosis and throughout gestation in 10 serially followed cases with TOF/APVS and 
one case with APVS/IVS. 
(TOF, Tetralogy of Fallot; APVS, absent pulmonary valve syndrome; IVS, intact 
ventricular septum) 
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Figure 9 
 
 
 
Figure 9 Fetal Z-score values of left pulmonary arteries (LPA) at time of 
diagnosis and throughout gestation in nine serially followed cases with TOF/APVS 
and one case with APVS/IVS. 
(TOF, Tetralogy of Fallot; APVS, absent pulmonary valve syndrome 
IVS, intact ventricular septum) 
 
 
 
 
 
 30 
 
 First trimester diagnosis was achieved in thirteen fetuses (18.3%), second 
trimester was achieved in 62% of fetuses and the diagnosis was made 
within the third trimester in 16.9% of fetuses. In 2.8% no information on 
time of diagnosis was obtained. Detailed information on patients with a first 
diagnosis is shown in figure 10. 
 
Figure 10 
 
 
Figure 10 Flowchart of thirteen APVS cases diagnosed in first trimester and 
outcome according to the type of APVS 
 (TOF, Tetralogy of Fallot; APVS, absent pulmonary valve syndrome; 
IVS, intact ventricular septum; IUD, intrauterine demise; TOP, termina-
tion of pregnancy) 
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Nine of thirteen cases (69.2%) were diagnosed as having TOF/APVS 
whereas four fetuses presented with APVS/IVS (30.8 %). Within the group 
of first trimester diagnosis, hydrops fetalis was present in nine cases and 
in all nine fetuses an increased NT was measured (figure 11). 
 
 
 
 
Figure 11 
 
 
 
Figure 11 Fetus (13 weeks of gestation) with TOF/APVS and cystic hygroma. 
(TOF, tetralogy of Fallot; APVS, absent pulmonary valve syndrome) 
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Of those, five cases presented with TOF/APVS (55,5%) and all four cases 
with APVS/IVS and first trimester diagnosis presented with hydrops fetalis. 
Abnormal Doppler profiles with reversal flow at the level of the pulmonary 
annulus, the main pulmonary trunk or to-and-fro blood within the umbilical 
artery was detected in all of those nine fetuses (figure 12a, b). 
Figure 12a 
 
 
 
Figure 12a Blood flow across pulmonary fibrous annulus in fetus of 13 weeks of 
gestation with TOF/APVS. Continuous wave Doppler recording 
demonstrates pulmonary to-and-fro-flow.  
(TOF, Tetralogy of Fallot; APVS, absent pulmonary valve syndrome) 
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Figure 12b 
 
 
Figure 12b Fetus (13 weeks of gestation) with TOF/APVS and cystic hygroma; to-
and-frow-flow in the umbilical artery. 
(TOF, Tetralogy of Fallot; APVS, absent pulmonary valve syndrome) 
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5. Discussion 
 
 The findings of our study revealed important differences between the two 
main entities ocurring with APVS, fetuses with TOF/APVS and APVS/IVS.        
First, the distribution with 83.1% of cases presenting with TOF/APVS and 
only 16.9% having APVS/IVS reflects previous reports with much lower 
numbers included (12,13,28,30). In 18.3% of cases of our cohort the 
diagnosis was made within the first trimester. Differences in health care 
systems with established detailed anomaly scan together with first 
trimester screening versus second trimester screening might  account for 
this high number of first trimester diagnosis in our cohort compared to 
results from the high number of first trimester diagnosis ranging from 20 to 
37 wks in 12 cases or 18 to 39 wks in 21 cases in a report from the Toronto 
group with reported diagnosis ranging from 20 to 37 wks in 1 case or 18 
to 39 wks in 21 cases in a report from Philadelphia (28,30). Results from 
Gottschalk et al. and Galindo et al. underline the feasibility of first trimester 
diagnosis in those cases (12,13,5). The high number of aneuploidies 
associated with APVS and the distribution of aneuploidies in our cohort 
with microdeletion 22q11.2 as the most common aneuploidy being very 
frequently associated with TOF/APVS is in line with previous series and 
underlines that prenatal counselling should include chromosomal testing 
including microdeletion 22q11.2(12,13,30). 
 Second, all fetuses with a first trimester diagnosis died or were terminated 
prior 24 wks due to presence of hydrops or chromosomal anomalies. Nine 
of those thirteen cases presented with TOF/APVS, in those four hydrops 
was present at the time of diagnosis and in two fetuses patency of the DA 
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was ascertained on first trimester ultrasound. Further three cases of 
APVS/IVS were diagnosed with hydrops fetalis and in all three cases 
patency of DA was diagnosed. In older series a patent arterial duct in 
APVS has been described in a few second and third trimester fetuses, 
whereas Zach et al. proposed that intrauterine closure of the DA would be 
essential for survival in the condition of APVS as patency of the arterial 
duct would result in important aortopulmonary shunting and right sided 
cardiac failure (34). 
No fetuses survived after first trimester diagnosis of APVS in our series 
and this further underlines this statement. In TOF/APVS with patent DA, 
hydrops fetalis is likely to develop early in gestation due to diastolic runoff 
via the DA into the pulmonary branch arteries and the right ventricle thus 
increasing the risk of right ventricular overload and fetal heart failure. This 
may result in high venous pressure and subsequent evolution of hydrops 
fetalis as was the case in nine of the thirteen cases in our cohort. Yeager 
et al. speculated that in APVS/IVS with a normal sized patent duct the end-
diastolic RV pressure would equal the aortic diastolic pressure and the 
authors hypothesized that the consequence would be a RV dysfunktion 
(33). In line with this theory the live born three cases with APVS/IVS in our 
cohort had a restrictive DA well below the normal size probably preventing 
the RV from severe dysfunktion. 
 Third, absence of DA only occured in fetuses with TOF/APVS, fetuses 
presented with APVS/IVS had a patent DA. Previously, absence of DA has 
been reported to be associated with TOF/APVS and it has been 
speculated that absence of DA might be in part responsible for the 
constantly observed aneurysmatical dilation of the branch pulmonary 
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arteries in this condition (9,10,20). Further Fischer et al. hypothesized that 
absence of DA and consecutive absence of right –to-left shunt through the 
duct also might contribute to maldevelopment of the pulmonary valve (11). 
However, there are a few cases with TOF/APVS and a patent arterial duct 
and patency of the arterial duct is more commonly observed in patients 
with the rare entity of APVS/IVS. It has therefore been speculated that 
aneurysmatical dilation of branch pulmonary arteries results from both 
primary underdevelopment of the pulmonary valve leaflets with an 
obstructive ring and high right ventricular stroke volume with severe 
pulmonary insufficiency (9,10,20,33). Interestingly, in contrast to 
Gottschalk et al. who speculated that first trimester diagnosis of APVS 
would rely on the presence of a typical to-and- fro blood within the DA, 
umbilical artery or middle cerebral artery besides the presence of a large 
VSD or a RAA, we describe four first trimester cases of TOF/APVS with 
already marked dilation of PA branches and MPA. Although we could not 
ascertain information on patency of the DA in those cases hydrops was 
present and it might be speculated that the observed severe pulmonary 
regurgitation lead to enlarged PA dimensions early in pregnacy. 
 Marked dilation of the PA branches was a constant finding at the time of 
the second trimester anomaly scan in cases of TOF/APVS and absent DA 
in our cohort whenever assessed. This is in keeping with observations by 
Galindo et al. and support the assumption that a combination of volume 
load and high pulmonary vascular resistence in the fetus might contribute 
to enlargement of PA branch in case of absent DA (10). This effect might 
be further enhanced by pulmonary regurgitation resulting in higher right 
ventricular stroke volume. Again in cases of APVS/IVS with narrow, 
 37 
 
however patent DA, massive dilatation of the PA branches was not seen 
in our cohort as in the series by Gottschalk et al. (13). From a clinical 
perspective, in our series over all survival rate after prenatal diagnosis of 
TOF/APVS was 49.1% compared to 37.5% in APVS/IVS and reached 0% 
in actively managed live births in TOF/APVS and APVS/IVS, respectively. 
These numbers are favourable compare to data from Gottschalk et al. and 
the reported 14% by Glindo et al. (28,24). Both series included also first 
trimester diagnosis. The results are comparable to the 50% survival 
reported by Wertaschnigg et al. from the initial diagnosis but lower than 
the 86% on an intention to treat basis, as well as the 71% survival to birth 
for TOF/APVS and 83% for APVS/IVS with survival from subjects born 
alive being 80% by Szwast et al. (28,30). However the latter two reports 
are from Northern America with different health care systems and did not 
include cases with first and early second trimester diagnosis. This might 
constitute a selection bias in favour of less unfavourable cases. There 
have been different notions on survival of actively managed patients in the 
last decade ranging from 25% to 80%, significantly depending on the 
underlying lesion (28,30, 2,8). In APVS/IVS survival rate was 100 % being 
higher as previously reported. However, we only had three patients with 
intention -to-treat and in those patients APVS/IVS occured as isolated 
APVS with a biventricular physiology with a normal tricuspid annulus and 
a normal or dilated ventricle. Recently one fetus with APV/IVS and a non-
compacted RV, where single ventricle physiology is expected, has been 
diagnosed in our cohort. This constitutes a signifiant risk factor with 
consideration for heart transplantation. Prediction of outcome by 
echokardiographic parameters showed inconsistent results including a 
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higher pulmonary artery valve-to- Ao valve annular ratio and severe left 
ventricular dysfunktion as the most accurate variables (20,12,28,8). 
PAV/AoV ratio was higher in APVS/IVS cases in our series, however 
pulmonary artery valve-to-aortic valve annular ratio was similar in 
TOF/APVS who survived or did not survive. This is in contrast to findings 
by Szwast et al. In their report of 15 fetuses with TOF/APVS a higher 
pulmonary artery valve –to-aortic valve annular ratio and severe left 
ventricular dysfunktion were more common in non survivors and this might 
be due to the smaller number of individuals included in their study. Due to 
the retrospective charachter of our study, we did not assess left ventricular 
dysfunktion. 
 
 
6. Limitations 
 
 
 The study is limited by its retrospective milticenter design. Some subjects 
were lost to follow up and data on postnatal outomes were difficult to 
ascertain due to the multicenter approach. The strenght of the study is its 
large cohort, to date, to the best of our knowledge the largest 
contemporary of APVS with a prenatal diagnosis. In conclusion we report 
on a large contemporary cohort of APVS with prenatal diagnosis. Two 
main subtypes, TOF/APVS and APVS/IVS were diagnosed. The anomaly 
can be accurately diagnosed by fetal echocardiography in the first and  
early second trimester. The outcomes of APVS rely significantly on the 
underlying lesion. Outcomes remain guarded, especially if first trimester 
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diagnosis is included into the analysis due to associated karyotypic 
anomalies and the presence of hydrops fetalis. 
 
 
 
 
 
7. Summary: 
 
Objective: 
 To analyze the spectrum of prenatally diagnosed absent pulmonary valve 
syndrome (APVS) and the outcome from diagnosis onwards. Fetuses with 
APVS and tetralogy of Fallot (TOF/APVS) and with APVS and intact 
ventricular septum(APVS/IVS) were included. 
 
Method: 
 Multicenter retrospective study of the International Prenatal Cardiology 
 Collaboration Group(IPCCG). Clinical und echocardiographic databases 
of nine referral centers were rewiewed from 2012-2016. Various clinical 
und echocardiographic parameters were retrieved. 
 
Results: 
 The cohort included 71 cases, 59 with TOF/APVS and twelve with 
APVS/IVS. In 3% of cases the diagnosis was achieved within the first 
trimester. Association with hydrops fetalis was high within the first trimester 
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(69%). No fetus with known outcome survived after first trimester 
diagnosis. Karyotype anomalies occured in 44% with microdeletion 
22q11.2 beeing the most frequent (21%). Intrauterine fetal demis (IUD) 
occured in 14.5%. Pulmonary artery dimensions were increased in all 
cases of TOF/IVS. Survival to birth was 49.1% in TOF/APVS und 37.5% 
in APVS/IVS. Survival beyond the neonatal period in actively managed 
neonates was 40% in TOF/APVS and 37.5% in APVS/IVS. 
 
Conclusion: 
 Diagnosis of APVS ist feasible within the first trimester. Outcomes remain 
guarded, especially if first trimester diagnosis is included into the analysis 
due to associated karyotypic anomalies and the presence of hydrops 
fetalis. 
 
 
8. Zusammenfassung: 
 
Ziel: 
Die Diagnose und das Outcome von pränatal diagnostizierten Fällen mit 
`absent pulmonary valve syndrome` soll dargestellt werden.  
  
Methode: 
Dies ist eine retrospektive Multizenteranalyse aus neun europäischen 
Zentren. Diese Vorgehensweise wurde aufgrund der Seltenheit der Entität 
so gewählt. Die Daten wurden zwischen 2012-2016 gesammelt.  
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Resultate: 
Insgesamt konnten einundsiebzig Fälle eingeschleust werden. Davon 
waren 59 Fälle mit TOF/APVS und zwölf Fälle mit APVS/IVS. In 18.3% der 
Fälle konnte eine Diagnose im ersten Trimenon gestellt werden. 69% der 
Feten mit Diagnose im ersten Trimenon entwickelten einen Hydrops 
fetalis. Alle Feten mit Diagnose im ersten Trimenon kamen nicht lebend 
zur Welt. In 44% der Fälle mit Information wurde eine chromosomale 
Anomalie nachgewisen. Davon war mit 21% der Fälle die Mikrodeletion 
22q11.2 die häufigste Anomalie. In 14.5 der Fälle wurde ein intrauteriner 
Fruchttod beobachtet. In den Fällen mit APVS/IVS waren die 
Durchmesser der Pulmonarterien erhöht. Nach intrauteriner 
Diagnosestellung überlebten 49.1% der Fälle in TOF/APVS und in 37.5% 
der Fälle mit APVS/IVS. In Neugeborenen mit Intention to treat überlebten 
40% in TOF/APVS und 37.5 in APVS/IVS. 
  
Schlußfolgerung: 
Die Diagnose eines APVS kann im ersten Trimester erreicht werden. Die 
Prognose bei betroffenen Feten muß als zurückhaltend eingestuft werden, 
speziell im Falle einer Diagnose im ersten Trimester aufgrund von 
assoziierten Karyotypanomalien und einem gleichzeitig vorhandenen 
Hydrops fetalis. 
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9. List of abbreviations 
 
AVV                              atrioventricular valve 
 
APVS                           absent pulmonary valve syndrome 
 
CTR                             cardiothoracic ratio 
 
 
DA                                ductus arteriosus 
 
 
LPA                               left pulmonary artery 
 
IVC                               inferior vena cava 
 
NT                                nuchal tranlucency 
 
PA                                 pulmonary artery 
 
PaV                               pulmonary valve 
 
PA-V/AoV                     Pulmonary valve/Aortic valve 
PCC                             primary cardiac crescent 
 
RPA                              right pulmonary artery 
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RAA                           right aortic arch 
 
RVOT                        right ventricle outflow tract 
 
TA                              truncus arteriosus 
 
 
TOP                           termination of pregnacy 
 
TOF/APVS                    tetralogy of Fallot/ absent pulmonary valve syndrome 
 
UV                              umbilical vein 
 
VSD                           ventricular septum defect 
 
VV                               vitalline vein 
 
Wks                             weeks 
 
CNS                             central nervous system 
 
4CV                             4 chamber view 
 
 
 
 44 
 
 
10. List of tabelles and figures 
 
Table 1 General information of study population according to type of 
APVS and additional level of significance, expressed by p-
valves…………………………………………………page 20 
 
Table 2 Extracardiac anomalies according to type of APVS. 
……………………………………………………….. page 22 
 
Table 3 Distribution of fetuses with known karyotyping according to 
                    type of APVS………………………………………..page 23 
                 
Table 4 Fetal echocardiographic findings according to type of APVS 
and additional level of significance, expressed by p-values. 
……………………………………………………….. page 25 
 
Figure 1 Fetus with TOF/APVS and dilated RPA and LPA. 
……………………………………………………… . page 10 
 
Figure 2 Fetus (21 weeks of gestation) with APVS, ventricular septum 
                   defect and right aortic arch…………………………page 11  
  
 
 
 45 
 
 
 
 
Figure 2 Blood flow across pulmonary fibrous annulus in fetus of 20 
weeks of gestation with APVS, ventricular septum defect and 
right aortic arch. Continuous wave Doppler recording demon-
strates pulmonary stenosis with high-velocity antegrade flow 
(2,36 m/s) and severe regurgitation with retrograde flow into 
right ventricle…………………………………………page 11 
 
Figure 3 Fetus of 31 weeks of gestation with APVS/IVS. Ductal arch        
                    view with color Doppler demonstrates:  
A) patent DA with blood flow (big arrow) and dilated LPA and 
RPA 
B) severe pulmonary regurgitation (arrow) across pulmonary 
fibrous annulus  
 ………………………………………………………   page 12 
 
Figure 4 The same fetus of 31 weeks of gestation with APVS/IVS. On 
                    long-axis view of the LVOT, IVS (arrow) without any interven-
tricular shunt on color Doppler visuized. …………  page 13 
 
 
 
 
 
 46 
 
Figure 5 Fetus of 21 weeks of gestation with APVS, ventricular septum  
                   defect and right aortic arch.    
A) On three vessels view dilated pulmonary arteries (arrows) 
are shown;  
B) B) Short-axis view at the level of the great vessels visual-
izes dilated main pulmonary artery (MPA), left (LPA) and 
right (RPA) pulmonary branches and severe pulmonary re-
gurgitation (arrow) across narrow pulmonary fibrous annu-
lus.  
…………………………………………………………… page 14 
 
 
 
Figure 6 Flowchart of overall study population and outcome according  
                   to the type ofAPVS………………………………………page 21 
 
Figure 7 Fetal Z-score values of main pulmonary arteries (MPA) at time  
                   of diagnosis and throughout gestation in 11 serially followed  
                   cases with TOF/APVS and one case with APVS/IVS. 
 …………………………………………………………… page 27 
 
 
Figure 8 Fetal Z-score values of right pulmonary arteries (RPA) at time        
                 of diagnosis and throughout gestation in 10 serially followed 
                cases with TOF/APVS and one case with APVS/IVS. 
………………………………………………………… page 28 
 47 
 
 
Figure 9 Fetal Z-score values of left pulmonary arteries (LPA) at time 
                   of diagnosis and throughout gestation in nine serially followed  
                   cases with TOF/APVS and one case with APVS/IVS. 
………………………………………………………… page 29 
 
Figure 10 Flowchart of thirteen APVS cases diagnosed in first trimester  
                    and outcome according to the type of APVS 
 …………………………………………………………page 30 
 
Figure 11 Fetus (13 weeks of gestation) with TOF/APVS and cystic hy   
                    groma. 
                    …………………………………………………………page 31 
 
 
 
Figure 12a Blood flow across pulmonary fibrous annulus in fetus of 13 
weeks of gestation with TOF/APVS. Continuous wave Dop-
pler recording demonstrates pulmonary to-and-fro-flow.  
………………………………………………………page 32 
 
 
  
Figure 12b Fetus (13 weeks of gestation) with TOF/APVS and cystic hygroma; to-  
                       and-frow-flow in the umbilical artery. 
(TOF, Tetralogy of Fallot; APVS, absent pulmonary valve syndrome) 
…………………………………………………………….. page 33 
 48 
 
 
11. References:  
1. Allan LD, Sharland GK, Milburn A et al. Prospective diagnosis of 1006 
consecutive cases of congenital heart disease in the fetus. J Am Coll 
Cardiol 1994; 23:1452-1458.  
2. Alsoufi B, Williams WG, Hua Z et al. Surgical oucomes in the tratment 
of patients with tetralogy of fallot and absent pulmonary valve. European 
Journal of cardio- Thoracic Surgery 2007; 31:354-359.  
3. Aramian A, Gembruch U, Geipel A et al. Ebsteins anomaly oft he 
tricuspid valve in association with tetralogy of fallot and absent pulmonary 
valve syndrome. Fetal Diagn Ther 2011; 30: 153-156 
4. Berg C, Thomsen Y, Geipel A et al. Reversed end diastolic flow in the 
umbilical artery at 10-14 wks of gestation is associatd with absent 
pulmonar valve syndrome. Ultrasound Ostet Gynecol 2007; 30:254-258.  
5. Becker R, Schmitz L. Guschmann m et al. Prenatal diagnosis of familal 
absent pulmonary valve syndrome. Case report and review oft he 
literature: Ultrasound Obstet. Gynecol 2001; 17: 263-267.  
6. Carvahlo JS, Ho SY, Shinebourne EA. Sequential segmental analysis 
in complex fetal cardiac abnormalities: a logical approach to diagnosis. 
Ultrasound Obstet Gynecol 2005; 105-111 
7. Chen JM, GlicksteinJS, Margossian R et al. Superior oucomes of repair 
in infants and neonates with tetrallogy of Fallot with absent pulmonary 
valve syndrom. J Thorac Cardiovas Surg 2006; 1099-1104. 
 8. Donofrio MT, Jacobs ML, Rychik J. Tetralogy of Fallot with absent 
pulmonary valve: Echocardiographic morphometric features oft he right –
sided structures and their relationship to presentation and outcome. 
 49 
 
Journal oft he Amerian Society of echokardiography 1997; 10: 556-561  
 
9. Emmanouilides GC, Thanopoulos B, Siassi B et als Agenesis of ductus 
arteriosuassociated with the syndrome of tetralogy of fallot and absent 
pulmonary valve. Am J Cardiol 1976; 37:403-409.  
10. Ettedgui JA, Sharland HG, Chita SK et al. Absent pulmonary valve 
syndome with ventricular septal defect: role oft he arterial duct. Am J 
Cardiol 1990; 66: 233-234.  
11. Fischer DR, Neches WH, Beerman LB et al. Tetralogy of Fallot with 
absent pulmonary valve syndrom. J thorac Cardiovas Surg 2006; 1099-
1104 
12. Galindo A, Gutier, Del Rio M et al. Prenatal diagnosis and outcome for 
fetuses with congenital absence ot the pulmonary valve. Ultrasound 
Obstet Gynecol 2006; 28:32-39.  
13. Gottschalk I, Jehle C, Herberg U et al. Prenatal diagnosis of absent 
pulmonary valve from the 1st trimester inward: novel insights into 
pathophysiology, associated conditions and outcome of a rare cardiac 
defect. Ultrasound Obstet Gynecol; doi: 10.1002/uog.15977  
14. Ilbawi MN, Fedorchik J, Muster AJ et al. Surgical approach to severly 
smpomatik newborn infents with tetralogy of Fallot and absent pulmonary 
valve. J Thorac Cardiovas Surg 1986; 91: 584-589.  
15. Jacobson C. et al: Core neuropschological characteristics of children 
and adolescents with 22q11.2 deletion. J Intellect Diabil Res. 54(8): 701-
13,2010 
16. Jordaan HV.Cardiac size during prenatal development. Obstet 
Gynecol 1987; 69:854-858.  
 50 
 
 
17. Latio K, Gembruch U, Geipel et al. Tricuspid atresia with absent 
pulmonary valve and intact ventricular septum: intrauterine course and 
outcome of an unusual congenital heart defect. Ultrasound Obstet 
Gynecol 2010; 35:243-245.  
18. Lev M, Eckner FA. The pathologic anatomy of tetralogy of Fallot and 
variations. Dis Chest 1964; 45:251-261 
19. McDonell BE, Raff GW, Gaynor JW et al. Outcome after repair of 
tetralogy of Fallot with absent pulmonary valve. Ann Thorac Surg 1999; 
67:1391-1396.  
20. Moon-Grady AJ, Tracy TA, Brook MM et al. Value of clinical and 
echocardiographic features in predicting outcome in the fetus, infant and 
child with tetralogy of fallot with absent pulmonary valve complex. Am J 
Cardiol 2002; 89:1280-1285.  
Nasrallaf A, Williams RL, Nouri S. Absent pulmonary valve in tetralogy of 
fallot: clinical and angiographic considerations with review oft he literature. 
Cardiovasc Dis. 1974; 1: 392-299  
21. Norgaard et al 2006  
22. Pasquinin l, Mellander M, Seale A et al. Z-scores oft he fetal aortic 
isthmus and duct: an aid to assessing arch hypoplasie. Ultrasound Obstet 
Gynecol 2007; 29:628-633  
23. Rabinovitch M, Grady S, David I et al. Compression of intrapulmonary 
bronch by abnormally arteries associated with absent pulmonary valves. 
Am J Cardiol 1982; 50: 804-813.  
24. Rao B, Anderson RC, Edwards JE. Anatomic variations in the tetralogy 
of Fallot. Am Heart J 1871; 81:361-371 
 51 
 
25. Razani RS, Sharland G, Simpson JM. Pranatal diagnosis by 
echocardiogram and outcome of absent pulmonary valve. AM J Cardiol 
2003; 91:429-432  
26. Schneider C, McCrindle BW, Carvahlo JS et al. Development of z-
sores for fetal cardiac domensions from echocardiography. Ultrasound 
Obstet Gynecol 2005; 26:599-605. 
27. Sohn, Cristof, Holzgreve, Wolfgang (2012): Ultraschall in Gynäkologie 
und Geburtshilfe. 3. Aufl.s.I.: Georg Thieme Verlag KG. Online verfügbar 
Verlag KG.  
28. Szwast A, Tian Z, McCann m et al. Prospective diagnosis of 1006 
consecutevive cases of congenital heart diesase in the fetus. J Am Coll 
Cardiol 1994; 23:1452-1458.  
29. Volpe P, Paladini D, Marasini M et al. Characteristics, associations and 
outcome of absent pulmonary valve syndrome in the fetus. Ultrasound 
Obstet Gynecol 2004; 24:623-628 
30. Wertadchnigg D, Jaeggi M, Chitayat D et al. Prenatal diagnosis and 
outcome of absent pulmonary valve syndrome: contemprary single-centre 
experience and review of the literature. Ultraschound Obstet Gynecol 
2013; 41:162-167 
31. Woodward, PaulaJ.; Kennedy, anne; Sohaey, Roya; Byrne, Janice 
L.B.; Oh, Karen Y.; Puchalski, Michael D.: Diagnostik imaging. Third 
edition.  
32. Yagel S, Cohen SM, Achiron R. Examination oft he fetal heart by five 
short –axis viwes: a proposed screening method for comprehensive 
cardiac evaluation. Ultrasound Obstet Gynecol 2001, 17: 367-369.  
33. Yeager SB, van der Velde ME, Waters BL et al. Prenatal role oft he 
 52 
 
ductus arteriosus in absent pulmonary valve syndrome. Echocardiography 
2002; 19:489-493. 
34. Zach M, Beitzke A, Singer H et al. The syndrome of absent pulmonary 
valve and ventricular septal defects-anatomical features and embryonic 
considerations. Basic Res Cardiol 1979; 74:54-68.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 53 
 
12. Note of thanks                                                              
A special note of thanks goes to Prof. R. Axt- Fliedner for all his 
support. It was a great honour for me to work with him on this 
project. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 54 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
